<DOC>
	<DOCNO>NCT01756482</DOCNO>
	<brief_summary>This study evaluate antiviral effect GS-5806 healthy adult infect strain Respiratory Syncytial Virus .</brief_summary>
	<brief_title>Safety Efficacy Study GS-5806 Healthy Volunteers Infected With Respiratory Syncytial Virus ( RSV )</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Healthy male female Between 18 45 year old Body Mass Index 18 33 kg/m2 Acute chronic medical illness Positive Human Immunodeficiency Virus , Hepatitis B C Nose nasopharynx abnormality Abnormal lung function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Respiratory</keyword>
	<keyword>Syncytial</keyword>
	<keyword>Virus</keyword>
	<keyword>Infections</keyword>
	<keyword>RSV</keyword>
</DOC>